Stock Events

ANI Pharmaceuticals 

€55.5
2
+€0+0% Thursday 14:29

Statistics

Day High
55.5
Day Low
55
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
1.24B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

29FebConfirmed
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
0.13
0.51
0.9
1.28
Expected EPS
0.85
Actual EPS
1

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BSFA.F. It's not an investment recommendation.

About

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Show more...
CEO
Mr. Nikhil Lalwani
Employees
600
Country
US
ISIN
US00182C1036
WKN
000A1W15D

Listings